North Carolina Republicans file one of the most restrictive abortion bans in the country
RALEIGH, N.C. (WNCN) — State lawmakers are considering what would be one of the most restrictive abortion bans in the country.
House Bill 804, filed by Republican Representative Keith Kidwell, would make abortion after conception illegal except only to save the life of the mother. There are no exceptions for rape or incest.
Representative Kidwell and other Republican lawmakers didn't respond to a request for an interview.
The bill defines an unborn child as 'an individual living member of the homo sapiens species from fertilization until birth, including the entire embryonic and fetal stages of development.'
If the bill becomes law, anyone involved in performing or receiving an abortion could be found guilty of a felony, which in North Carolina means they could spend up to life in prison. It also allows for physicians or medical professionals to have their licenses revoked if they're involved in administering abortions.
In a statement, a Planned Parenthood representative said in part, 'Abortion is a critical component of comprehensive reproductive health care, and everyone deserves access to the care they need, without politicians controlling when, how, or why.'
The bill was filed on Friday and hasn't yet been referred to committee.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
15 minutes ago
- Associated Press
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics, Inc. to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
WILMINGTON, Del., June 12, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ('NRx Pharmaceuticals', 'NRx' or the 'Company'), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., ('HOPE,' or the 'Company'), a multi-site clinical care delivery organization and wholly-owned subsidiary of NRx, today announced participation in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference, scheduled for June 16–17, 2025. Dr. Jonathan Javitt, Founder, Chairman and Chief Executive Officer of NRx Pharmaceuticals and Co-CEO of HOPE, will deliver a corporate presentation highlighting the company's latest advances. The presentation will be available on demand to registered attendees beginning at 7:00 a.m. Eastern Time on Monday, June 16, 2025. In addition, the company will be participating in one-on-one meetings with investors throughout the conference. Please request 1:1 meetings on the HCW conference website listed below. Event Details: About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy, for suicidal treatment-resistant bipolar depression and chronic pain. NRx plans to file an NDA for Accelerated Approval for NRX-101 in patients with bipolar depression and suicidality or akathisia. NRX-101 additionally has potential as a treatment for complicated UTI. NRx recently filed an Abbreviated New Drug Application (ANDA) for NRX-100 (preservative free IV ketamine) for use in ketamine's currently approved indications. Additionally, the Company has initiated a New Drug Application filing for NRX-100 for the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality and has filed a patent for this novel formulation with the US Patent and Trademark Office. About HOPE Therapeutics, Inc. HOPE Therapeutics, Inc. ( ), a subsidiary of NRx Pharmaceuticals, is a Healthcare delivery company that is building a best-in-class network of interventional psychiatry clinics to offer ketamine, transcranial magnetics stimulation (TMS), and other lifesaving therapies to patients with suicidal depression and related disorders, together with a digital therapeutic-enabled platform designed to augment and preserve the clinical benefit of NMDA-targeted drug therapy. Notice Regarding Forward-Looking Statements The information contained herein includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These statements include, among others, statements regarding the satisfaction of closing conditions necessary to consummate the acquisition of Kadima, Neurospa and Dura, and obtaining financing necessary to consummate the acquisitions. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as 'may,' 'will,' 'should,' 'would,' 'expect,' 'plan,' 'believe,' 'intend,' 'look forward,' and other similar expressions among others. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy, liquidity, whether the USPTO approves the Company's patent, and whether the FDA will approve the Company's NDA. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's website at Except as may be required by applicable law, The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, whether as a result of new information, future events or otherwise. View original content to download multimedia: SOURCE NRx Pharmaceuticals, Inc.
Yahoo
19 minutes ago
- Yahoo
Race for Rockland County Executive is on: Parietti on November ballot on 'Good Gov' line
NEW CITY -- Ramapo resident Michael Parietti officially joined the ballot Wednesday as a candidate for Rockland County executive in the Nov. 4 election. The Rockland Board of Elections affirmed that Parietti amassed the minimum 1,500 signatures on petitions to qualify for the ballot on the independent "Good Gov" line. Parietti and his supporters filed more than 3,000 names with the board on May 27. Republican County Executive Ed Day challenged the petitions, but the Board of Elections commissioners sustained the signatures beyond the minimum needed. The commissioners, Democrat Allison Weinraub and Republican Patricia Giblin, informed Parietti by letter on Wednesday. "Upon examination of the specific objection, we hereby rule that the said objection is not sustained and the petition filed by Michael I. Parietti is hereby declared valid," the commissioners wrote. With that notification, Rockland's voters have a choice for county executive. Rockland Democrats did not field a candidate. Parietti said in a statement that more than 3,000 signatures represented broad support across the county. He said that Republican operatives attempted to knock him off the ballot by filing what he called baseless objections to his petitions. Parietti has said that in his numerous past campaigns, he'd never tried to knock a candidate off the ballot, arguing competition is good for the electoral process. 'They hired a high-priced consultant to try and silence voters,' Parietti said. 'But the signatures stood, and democracy won. Now voters can decide between entrenched political interests or new ideas and real accountability for the future of our county.' Day, a Republican seeking his fourth, four-year term as county executive, could not be immediately reached for comment on Wednesday. Day has said he's running on his record. His bread-and-butter issues have been keeping down county property taxes and maintaining services. Day took office in January 2014 with the county facing a deficit of $138 million. The county's 2024 budget paid off a $96 million bond to help cover the deficit. For 2025, the county government has accumulated a fund balance topping $300 million. Day has promoted decreases in county taxes in the last two fiscal years, including a 2% cut in the $876 million budget for 2025. He rose from a New City civic association president to county legislator before winning election as county executive in November 2013. He won his last two elections by comfortable margins. Day started the 2025 election season with no challengers before Parietti filed, as Rockland Democrats could not field a candidate. One registered Democrat, Ernest Morales, a retired police officer, made noise about seeking the party's nomination. But he and his supporters could not muster the required number of signatures to get on the ballot. Steve Lieberman covers government, breaking news, courts, police, and investigations. Reach him at slieberm@ Twitter: @lohudlegal. Read more articles and bio. Our local coverage is only possible with support from our readers. This article originally appeared on Rockland/Westchester Journal News: Rockland NY Executive Ed Day to face independent Mike Parietti Nov. 4
Business Wire
24 minutes ago
- Business Wire
Redfin Survey: Americans Are Torn on How Immigration, Tariffs Impact Housing Affordability
SEATTLE--(BUSINESS WIRE)--(NASDAQ: RDFN) — Over half of U.S. homeowners and renters (51.2%) strongly or somewhat agree with the following statement: 'Less immigration will result in fewer construction workers, and thereby fewer new homes, making homes more expensive.' That's according to a new survey commissioned by Redfin ( the technology-powered real estate brokerage. But much of the nation holds the opposite view; 38.5% of homeowners and renters strongly or somewhat agree with this statement: 'Less immigration will reduce demand for housing, making it more affordable.' Democrat respondents were more likely than Republican respondents to agree with the idea that less immigration will make homes more expensive: 67.1% vs 38.7%. These survey findings are from a nationally representative Redfin-commissioned survey of 4,000 U.S. homeowners and renters conducted by Ipsos March 28, 2025-April 28, 2025. The relevant survey question is: 'To what extent do you agree or disagree with the following statements in relation to recent and/or proposed changes to laws or policies that could affect the housing market?' U.S. homeowners and renters are also torn on how tariffs will impact the housing market. Over two-thirds (67.9%) strongly or somewhat agree with the following statement: 'Tariffs will cause price inflation and keep interest rates high.' But over one-third (34.7%) strongly or somewhat agree with this statement: 'Tariffs will help boost the U.S. economy so more people can afford homes.' Republican respondents were more likely than Democrat respondents to agree with the idea that tariffs will help boost the economy so more people can afford homes: 55.3% vs 23.9%. Redfin reported in April that nearly 1 in 4 U.S. residents are canceling plans to make a major purchase, such as a home or a car, because of President Trump's new tariff policies. 43% of U.S. Homeowners and Renters Are Worried About Impact of Tariffs on Housing Market More than 2 in 5 U.S. homeowners and renters (43.1%) feel very or somewhat worried about the effect tariffs could have on their local housing market/home values. Roughly one-third (33.1%) feel very or somewhat hopeful. When it comes to immigration, 40.7% of homeowners and renters feel very or somewhat hopeful about the effect deportations/fewer immigrants could have on the economy, while 26.3% feel very or somewhat worried. To view the full report, including charts and detailed methodology, please visit: About Redfin Redfin ( is a technology-powered real estate company. We help people find a place to live with brokerage, rentals, lending, and title insurance services. We run the country's #1 real estate brokerage site. Our customers can save thousands in fees while working with a top agent. Our home-buying customers see homes first with on-demand tours, and our lending and title services help them close quickly. Our rentals business empowers millions nationwide to find apartments and houses for rent. Since launching in 2006, we've saved customers more than $1.8 billion in commissions. We serve approximately 100 markets across the U.S. and Canada and employ over 4,000 people. Redfin's subsidiaries and affiliated brands include: Bay Equity Home Loans®, Rent.™, Apartment Guide®, Title Forward® and WalkScore®. For more information or to contact a local Redfin real estate agent, visit To learn about housing market trends and download data, visit the Redfin Data Center. To be added to Redfin's press release distribution list, email press@ To view Redfin's press center, click here.
